These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19705471)

  • 41. Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
    Pöpperl G; Tatsch K; Ruzicka E; Storch A; Gasser T; Schwarz J
    J Neural Transm (Vienna); 2004 Aug; 111(8):1041-52. PubMed ID: 15254792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
    Rektorova I; Srovnalova H; Kubikova R; Prasek J
    Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does reduced [(123)I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?
    Gamez J; Lorenzo-Bosquet C; Cuberas-Borrós G; Carmona F; Hernández-Vara J; Castilló J; Castell-Conesa J
    Clin Neurol Neurosurg; 2010 Dec; 112(10):870-5. PubMed ID: 20724066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodies.
    Yamamoto R; Takenoshita N; Inagawa Y; Kato H; Kaneshiro K; Kamiya T; Inagawa S; Saisho A; Tsugawa A; Mastumoto Y; Yoshimura M; Saito K; Shimizu S; Sato T
    Psychogeriatrics; 2023 Nov; 23(6):1036-1042. PubMed ID: 37726104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
    Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
    J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia.
    Song IU; Kim YD; Cho HJ; Chung SW; Chung YA
    Alzheimer Dis Assoc Disord; 2013; 27(1):51-5. PubMed ID: 22354157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies.
    Ziebell M; Andersen BB; Pinborg LH; Knudsen GM; Stokholm J; Thomsen G; Karlsborg M; Høgh P; Mørk ML; Hasselbalch SG
    J Nucl Med; 2013 Jul; 54(7):1072-6. PubMed ID: 23637201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.
    Di Giuda D; Camardese G; Bentivoglio AR; Cocciolillo F; Guidubaldi A; Pucci L; Bruno I; Janiri L; Giordano A; Fasano A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1937-48. PubMed ID: 22976499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Confirmation of
    Maltais DD; Jordan LG; Min HK; Miyagawa T; Przybelski SA; Lesnick TG; Reichard RR; Dickson DW; Murray ME; Kantarci K; Boeve BF; Lowe VJ
    J Nucl Med; 2020 Nov; 61(11):1628-1635. PubMed ID: 32198310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies.
    Walker RW; Walker Z
    Mov Disord; 2009; 24 Suppl 2():S754-9. PubMed ID: 19877236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
    Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
    Schuster JP; Buhl C; Archambaud F; Hardy P; Chouinard G; Prigent A; Corruble E
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):206. PubMed ID: 17362445
    [No Abstract]   [Full Text] [Related]  

  • 58. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies?
    Koch W; Hamann C; Welsch J; Pöpperl G; Radau PE; Tatsch K
    J Nucl Med; 2005 Nov; 46(11):1804-11. PubMed ID: 16269593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study.
    Liang CS; Ho PS; Yen CH; Yeh YW; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Huang SY
    Addict Biol; 2016 Jan; 21(1):196-204. PubMed ID: 25439653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new era of clinical dopamine transporter imaging using 123I-FP-CIT.
    Park E
    J Nucl Med Technol; 2012 Dec; 40(4):222-8. PubMed ID: 23160562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.